To include your compound in the COVID-19 Resource Center, submit it here.

Genentech reports additional OCEANS data

Genentech Inc. said Avastin bevacizumab plus carboplatin and gemcitabine followed by Avastin maintenance therapy led to

Read the full 163 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE